Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

IRON SCREEN, INCLUDING TIBC

Geisinger Epic Procedure Code:  LAB2556    Geisinger Epic ID:  14952

SPECIMEN COLLECTION
Specimen type: 

Plasma or serum 
 


Specimen required: 

1 mL of serum or plasma; minimum 0.2 mL



SPECIMEN PROCESSING
Processing instructions: 

Allow serum to clot. Centrifuge to separate serum or plasma within 2 hours of collection.


Transport temperature: 

Refrigerated (preferred) or room temperature.


Specimen stability: 

Room temperature: 4 days. Refrigerated: 7 days.


Rejection criteria: 

Hemolyzed specimens are not acceptable.



TEST DETAILS
Reference interval: 
 MaleFemale
Iron (ug/dL)45-17633-151
Transferrin Saturation (%)15-5515-55
IBC (ug/dL)250-425250-425

CPT code(s):  83540, 83550
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

Iron, Iron Binding Capacity


Methodology: 
Spectrophotometric (Colorimetric)
Synonyms: 

IRON SCREEN, TRANSFERRIN SATURATION, FESCRN


Clinical significance: 

Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician's ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated tranferrin. The percentage saturation is low in iron deficiency anemia and high in iron storage diseases.


Doctoral Director(s): 
Hoi-Ying Elsie Yu, PhD, DABCC, FADLM
Sheng-Ying (Margaret) Lo, PhD, DABCC
Review Date:  12/27/2024

Performing Locations